Transcutaneous Neurostimulator

Helps significantly reduce opioid withdrawal symptoms.
Bridge is the first FDA-cleared, drug-free, non-surgical device to use neuromodulation to aid in the reduction of symptoms associated with opioid withdrawal.

it is a small electrical nerve stimulator device that contains a battery-powered chip and wires that are applied around a patient''s ear. It requires a preion and is offered to qualified healthcare professionals with training.

The Bridge kit includes everything needed to apply the device.
In a study of 73 adult patients with opioid use disorder, a reduction in opioid withdrawal symptoms was observed when Bridge was used during active withdrawal. The study demonstrated Bridge to be:

FAST: Provides symptom relief beginning in as little as 20 minutes1
EFFECTIVE: May significantly reduce opioid withdrawal symptoms
Help users successfully progress in treatment:
88% of patients successfully transitioned into a medically assisted therapy (MAT) program

SAFE :
No reported side effects with minimal risks during device placement
0.17% Incidence of significant pain at the lead implantation site
0.91% Incidence of bleeding at the lead implantation site
0.91% Incidence of dermatitis at the lead implantation site
0% Incidence of syncope

Who Can Bridge Help?
Bridge can be used for patients*
experiencing opioid withdrawal symptoms, while undergoing treatment for opioid use disorder, when
• Initiating treatment
• Transitioning to naltrexone
• Tapering off medication-assisted treatment